Phillip T. Dean

Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement

Douglas B. Johnson, Mellissa J. Nixon, Yu Wang et al. · JCI Insight · 2018 · 159 citations · Full text

Life Sciences, Immunology, Oncology +17

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

Justin M. Balko, Luis J. Schwarz, Na Luo et al. · Science Translational Medicine · 2016 · 135 citations · Full text

Medicine, Cancer Biology, Oncology +12

Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2

Na Luo, Luigi Formisano, Paula I. González-Ericsson et al. · OncoImmunology · 2018 · 82 citations · Full text

Medicine, Immunology, Oncology +17

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

Derek A. Franklin, Joe T. Sharick, Paula I. González-Ericsson et al. · JCI Insight · 2020 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17

RGS10 physically and functionally interacts with STIM2 and requires store-operated calcium entry to regulate pro-inflammatory gene expression in microglia

Menbere Wendimu, Mohammed Alqinyah, Stephen A. Vella et al. · Cellular Signalling · 2021 · 19 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14